Powered by: Motilal Oswal
2025-11-28 11:51:02 am | Source: Accord Fintech
Sudeep Pharma lists at 24% premium on the BSE
Sudeep Pharma lists at 24% premium on the BSE

Sudeep Pharma has debuted at Rs 733.95 on the BSE, up by 140.95 points or 23.76% from its issue price of Rs 593.00.

The scrip is currently trading at Rs. 759.25, up by 166.25 points or 28.03% from its issue price.

It has touched a high and low of Rs. 762.00 and Rs. 726.00 respectively. So far 15.84 lakh shares were traded on the counter.

The offering, which was open for subscription between November 21, 2025 and November 25, 2025 was subscribed 93.71 times. The issue price was fixed at Rs 593.00 per share i.e. at upper end of price band of Rs 563-593 apiece.

Sudeep Pharma is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here